Please wait
false FY 0001786286 0001786286 2025-01-01 2025-12-31 0001786286 dei:BusinessContactMember 2025-01-01 2025-12-31 0001786286 2025-12-31 0001786286 2024-12-31 0001786286 2024-01-01 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:WarrantReserveMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-01-01 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantReserveMember 2025-01-01 2025-12-31 0001786286 ifrs-full:RetainedEarningsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-01-01 2025-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-12-31 0001786286 ifrs-full:WarrantReserveMember 2025-12-31 0001786286 ifrs-full:RetainedEarningsMember 2025-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-12-31 0001786286 DPRO:DragonflyInnovationsIncMember 2025-01-01 2025-12-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2025-01-01 2025-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2025-01-01 2025-12-31 0001786286 DPRO:PreviouslyReportedMember 2024-01-01 2024-12-31 0001786286 DPRO:ReclassificationAdjustmentMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ShareOptionsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2025-01-01 2025-12-31 0001786286 DPRO:CustomerRelationshipIntangibleAssetsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2025-01-01 2025-12-31 0001786286 DPRO:PatentMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-01-01 2025-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-01-01 2025-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:VehiclesMember 2025-01-01 2025-12-31 0001786286 DPRO:InventoryMember 2025-01-01 2025-12-31 0001786286 DPRO:InventoryMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-01-01 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-01-01 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-12-31 0001786286 ifrs-full:VehiclesMember 2025-12-31 0001786286 ifrs-full:PropertyPlantAndEquipmentMember 2025-01-01 2025-12-31 0001786286 ifrs-full:PropertyPlantAndEquipmentMember 2024-01-01 2024-12-31 0001786286 ifrs-full:RightofuseAssetsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:RightofuseAssetsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:BuildingsMember 2025-12-31 0001786286 ifrs-full:BuildingsMember 2024-12-31 0001786286 ifrs-full:BottomOfRangeMember 2025-12-31 0001786286 ifrs-full:TopOfRangeMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2024-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2024-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2025-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2025-01-01 2025-12-31 0001786286 DPRO:CommonStock1Member 2025-05-05 0001786286 2025-05-05 2025-05-05 0001786286 DPRO:BrokerWarrantsMember 2025-05-05 2025-05-05 0001786286 ifrs-full:OrdinarySharesMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember 2025-05-05 0001786286 2025-05-05 0001786286 DPRO:OverallotmentSharesMember 2025-05-05 0001786286 DPRO:OverallotmentSharesMember 2025-05-05 2025-05-05 0001786286 DPRO:CommonStock1Member 2025-06-12 0001786286 2025-06-12 2025-06-12 0001786286 DPRO:BrokerWarrantsMember 2025-06-12 2025-06-12 0001786286 ifrs-full:OrdinarySharesMember 2025-06-12 2025-06-12 0001786286 ifrs-full:WarrantsMember 2025-06-12 2025-06-12 0001786286 DPRO:CommonStock1Member 2025-07-21 0001786286 2025-07-21 2025-07-21 0001786286 DPRO:BrokerWarrantsMember 2025-07-21 2025-07-21 0001786286 DPRO:CommonStock1Member 2025-07-21 2025-07-21 0001786286 DPRO:CommonStock1Member 2023-06-01 2023-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 0001786286 2024-02-26 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 2024-02-26 0001786286 DPRO:BrokerWarrantsMember 2024-02-26 2024-02-26 0001786286 ifrs-full:WarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-03-27 0001786286 DPRO:PrefundedWarrantsMember 2024-03-26 0001786286 DPRO:PrefundedWarrantsMember 2025-12-31 0001786286 DPRO:CommonStock1Member 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 0001786286 2024-04-29 2024-04-29 0001786286 DPRO:BrokerWarrantsMember 2024-04-29 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 2024-04-29 0001786286 ifrs-full:WarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:PrefundedWarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:CommonStock1Member 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 0001786286 2024-08-21 2024-08-21 0001786286 DPRO:BrokerWarrantsMember 2024-08-21 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 2024-08-21 0001786286 ifrs-full:WarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:PrefundedWarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:CommonStock1Member 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 0001786286 2024-11-19 2024-11-19 0001786286 DPRO:BrokerWarrantsMember 2024-11-19 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 2024-11-19 0001786286 ifrs-full:WarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:PrefundedWarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:StockOptionsMember 2025-01-01 2025-12-31 0001786286 DPRO:StockOptionsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2025-01-01 2025-12-31 0001786286 2024-08-07 2024-08-07 0001786286 DPRO:OctoberWarrantsMember 2024-08-07 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-12-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2025-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2023-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2024-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2025-12-31 0001786286 DPRO:BrokerMember DPRO:MayIssuanceMember 2025-01-01 2025-12-31 0001786286 DPRO:BrokerMember DPRO:JuneIssuanceMember 2025-01-01 2025-12-31 0001786286 DPRO:BrokerMember DPRO:JulyIssuanceMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember DPRO:FebruaryIssuanceMember 2024-01-01 2024-12-31 0001786286 DPRO:BrokerMember DPRO:FebruaryIssuanceMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember DPRO:AprilIssuanceMember 2024-01-01 2024-12-31 0001786286 DPRO:BrokerMember DPRO:AprilIssuanceMember 2024-01-01 2024-12-31 0001786286 DPRO:BrokerMember DPRO:AugustIssuanceMember 2024-01-01 2024-12-31 0001786286 DPRO:BrokerMember DPRO:NovemberIssuanceMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember 2025-12-31 0001786286 DPRO:RangeOneMember 2025-01-01 2025-12-31 0001786286 DPRO:RangeOneMember 2025-12-31 0001786286 DPRO:RangeOneMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 DPRO:WarrantOneMember 2025-01-01 2025-12-31 0001786286 DPRO:WarrantOneMember 2025-12-31 0001786286 DPRO:WarrantTwoMember 2025-01-01 2025-12-31 0001786286 DPRO:WarrantTwoMember 2025-12-31 0001786286 DPRO:WarrantThreeMember 2025-01-01 2025-12-31 0001786286 DPRO:WarrantThreeMember 2025-12-31 0001786286 DPRO:WarrantFourMember 2025-01-01 2025-12-31 0001786286 DPRO:WarrantFourMember 2025-12-31 0001786286 DPRO:WarrantFiveMember 2025-01-01 2025-12-31 0001786286 DPRO:WarrantFiveMember 2025-12-31 0001786286 ifrs-full:WarrantsMember 2025-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 DPRO:DronesMember 2025-01-01 2025-12-31 0001786286 DPRO:CorporatesMember 2025-01-01 2025-12-31 0001786286 DPRO:DronesMember 2024-01-01 2024-12-31 0001786286 DPRO:CorporatesMember 2024-01-01 2024-12-31 0001786286 DPRO:CAMember 2025-12-31 0001786286 DPRO:CAMember 2024-12-31 0001786286 DPRO:USCountryMember 2025-12-31 0001786286 DPRO:USCountryMember 2024-12-31 0001786286 DPRO:CAMember 2025-01-01 2025-12-31 0001786286 DPRO:CAMember 2024-01-01 2024-12-31 0001786286 DPRO:USCountryMember 2025-01-01 2025-12-31 0001786286 DPRO:USCountryMember 2024-01-01 2024-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2025-01-01 2025-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2024-01-01 2024-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2025-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2024-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2025-01-01 2025-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2024-01-01 2024-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2025-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2024-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2025-01-01 2025-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2024-01-01 2024-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2025-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2024-12-31 0001786286 DPRO:CEOAndDirectorMember 2025-01-01 2025-12-31 0001786286 DPRO:CEOAndDirectorMember 2024-01-01 2024-12-31 0001786286 DPRO:CEOMember 2025-01-01 2025-12-31 0001786286 DPRO:CEOMember 2024-01-01 2024-12-31 0001786286 DPRO:SalaryAndCommissionMember 2025-01-01 2025-12-31 0001786286 DPRO:SalaryAndCommissionMember 2024-01-01 2024-12-31 0001786286 DPRO:ContractorFeesMember 2025-01-01 2025-12-31 0001786286 DPRO:ContractorFeesMember 2024-01-01 2024-12-31 0001786286 DPRO:DirectorsMember 2025-01-01 2025-12-31 0001786286 DPRO:DirectorsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2025-01-01 2025-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-12-31 0001786286 ifrs-full:CurrentMember 2025-12-31 0001786286 ifrs-full:CurrentMember 2024-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2025-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2024-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2025-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2024-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2025-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2024-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2025-12-31 0001786286 DPRO:NetMonetaryAssetsMember 2025-01-01 2025-12-31 0001786286 DPRO:NetMonetaryAssetsMember 2025-12-31 0001786286 DPRO:NetMonetaryAssetsMember 2024-01-01 2024-12-31 0001786286 DPRO:NetMonetaryAssetsMember 2024-12-31 0001786286 DPRO:NetMonetaryLiabilitiesMember 2025-01-01 2025-12-31 0001786286 DPRO:NetMonetaryLiabilitiesMember 2025-12-31 0001786286 DPRO:NetMonetaryLiabilitiesMember 2024-01-01 2024-12-31 0001786286 DPRO:NetMonetaryLiabilitiesMember 2024-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2025-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2025-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2025-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2025-01-01 2025-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-01-01 2024-12-31 0001786286 DPRO:ExpiringInTwoThousandTwentyNineToTwoThousandFortyFiveMember 2025-01-01 2025-12-31 0001786286 DPRO:ExpiringInTwoThousandFortyToTwoThousandFortyFiveMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember 2026-02-06 0001786286 ifrs-full:WarrantsMember 2026-02-06 2026-02-06 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember 2026-02-23 0001786286 DPRO:PrefundedWarrantsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-02-23 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember 2026-02-23 2026-02-23 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember DPRO:PrefundedWarrantsMember 2026-02-23 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember DPRO:PrefundedWarrantsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2026-02-23 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2026-02-23 2026-02-23 0001786286 DPRO:PrefundedWarrantsMember ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-03 0001786286 ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-03 0001786286 DPRO:PrefundedWarrantsMember ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-06 0001786286 ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-06 0001786286 DPRO:PrefundedWarrantsMember ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-10 0001786286 ifrs-full:OrdinarySharesMember DPRO:NonadjustmentEventsMember 2026-03-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CAD iso4217:CAD xbrli:shares xbrli:pure DPRO:Segment

 

.2

 

 

Draganfly Inc.

Consolidated Financial Statements

Years Ended December 31, 2025 and 2024

 

(Expressed in Canadian Dollars)

 

 

 

 

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of Draganfly Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Draganfly Inc. (the “Company”) as of December 31, 2025 and 2024, the related consolidated statements of comprehensive loss, changes in shareholders’ equity, and cash flows, for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and its financial performance and its cash flows for the years then ended, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion in accordance with the standards of the PCAOB.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

DMCL LLP  
CHARTERED PROFESSIONAL ACCOUNTANTS  

 

We have served as the Company’s auditor since 2018

Vancouver, Canada (PCAOB ID 1173)

March 24, 2026

 

 

 

 

Draganfly Inc.

Consolidated Statements of Financial Position

Expressed in Canadian Dollars

 

 

      December 31,   December 31, 
As at  Notes  2025   2024 
            
ASSETS             
Current Assets             
Cash and cash equivalents     $90,156,821   $6,252,409 
Receivables  4   1,041,582    573,390 
Inventory  5   3,903,139    1,532,263 
Prepaids and deposits  6   4,757,100    724,513 
Total current assets      99,858,642    9,082,575 
Non-current Assets             
Equipment  7   1,192,074    529,542 
Intangible assets      36,112    45,141 
Investments      71,429    14,286 
Receivable  4   -    156,200 
Right of use assets  8   229,616    372,344 
TOTAL ASSETS     $101,387,873   $10,200,088 
              
LIABILITIES AND SHAREHOLDERS’ EQUITY             
Current Liabilities             
Trade payables and accrued liabilities  10,17  $3,397,343   $2,399,187 
Customer deposits      417,641    466,295 
Deferred revenue  11   165,237    18,542 
Derivative liability  12,17   492,470    2,198,121 
Lease liabilities  9   143,624    154,147 
Total current liabilities      4,616,315    5,236,292 
              
Non-current Liabilities             
Deferred revenue  11   44,512    68,139 
Lease liabilities  9   130,251    273,874 
TOTAL LIABILITIES      4,791,078    5,578,305 
              
SHAREHOLDERS’ EQUITY             
Share capital  12   229,698,507    110,742,984 
Reserves – share-based payments  12   7,347,457    7,698,304 
Reserves - Warrants  12   126,534    3,776,428 
Accumulated deficit      (140,446,908)   (117,465,829)
Accumulated other comprehensive income (loss)      (128,795)   (130,104)
TOTAL SHAREHOLDERS’ EQUITY      96,596,795    4,621,783 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY     $101,387,873   $10,200,088 

  

Approved and authorized for issuance by the Board of Directors on March 24, 2026.

 

 “Kim Moody”   “Cameron Chell”
     

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4

 

 

Draganfly Inc.

Consolidated Statements of Comprehensive Loss

Expressed in Canadian Dollars

 

 

            
   For the years ended December 31, 
   Notes  2025   2024 
REVENUE           
Sales of goods  13  $6,869,815   $5,368,476 
Provision of services  13   861,348    1,192,579 
TOTAL REVENUE      7,731,163    6,561,055 
              
COST OF SALES  5   (6,409,827)   (5,162,851)
              
GROSS PROFIT      1,321,336    1,398,204 
              
OPERATING EXPENSES             
Amortization      9,028    11,285 
Depreciation  7,8   337,491    565,806 
Director fees  16   519,950    504,620 
Insurance      654,477    1,111,052 
Office and miscellaneous  2,9,14   5,883,533    2,287,884 
Professional fees  2   1,333,564    1,435,412 
Research and development      970,859    927,412 
Share-based payments  12,16   1,388,956    1,182,618 
Travel      1,107,610    231,431 
Employee and management expenses  2,16   9,906,834    7,880,180 
Total operating expenses      (22,112,302)   (16,137,700)
              
OTHER INCOME (EXPENSE)             
Change in fair value of derivative liability  12   (2,648,288)   1,842,618 
Finance and other costs      1,088,965    107,225 
Foreign exchange gain      (425,089)   268,537 
Gain (loss) on disposal of assets      20,758    11,432 
Gain (loss) on write-off of notes receivable      69,646    40,020 
Other income (expense)  15   (296,105)   (1,407,809)
NET LOSS FOR THE YEAR      (22,981,079)   (13,877,473)
              
OTHER COMPREHENSIVE INCOME (LOSS)             
Items that may be reclassified to profit or loss             
Foreign exchange translation      (62,977)   (9,944)
Items that will not be reclassified to profit or loss             
Change in fair value of equity investments at FVTOCI      64,286    (175,117)
COMPREHENSIVE LOSS FOR THE YEAR     $(22,979,770)  $(14,062,534)
              
Net loss per share             
Basic & diluted     $(1.46)  $(4.40)
Weighted average number of common shares outstanding - basic & diluted      15,715,424    3,156,891 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5

 

 

Draganfly Inc.

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

 

 

                                  
                      

Accumulated Other

Comprehensive

Income (Loss)

     
  

Number of

Shares

  

Share

Capital

  

Reserves – Share-Based

Payments

  

Reserves -

Warrants

  

Accumulated

Deficit

  

Change in

Fair Value

of

Investments

at FVTOCI

  

Exchange

Differences

on

Translation

of Foreign

Operations

  

Total

Shareholders’

Equity

 
Balance at December 31, 2023   1,969,566   $97,070,976   $6,870,139   $-   $(103,588,356)  $(434,303)  $489,260   $         407,716 
Shares issued for financing   1,477,208    10,384,145    -    -    -    -    -    10,384,145 
Share issue costs   -    (1,632,871)   509,454    -    -    -    -    (1,123,417)
Shares issued for the exercise of warrants   1,991,668    4,056,827    -    -    -    -    -    4,056,827 
Shares returned to treasury   (36,000)   -    -    -    -    -    -    - 
Shares issued for the exercise of RSUs   25,353    863,907    (863,907)   -    -    -    -    - 
Warrants   -    -    -    3,776,428                   3,776,428 
Share-based payments   -    -    1,182,618    -    -    -    -    1,182,618 
Net loss   -    -    -    -    (13,877,473)   -    -    (13,877,473)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (175,117)   -    (175,117)
Translation of foreign operations   -    -    -    -    -    -    (9,944)   (9,944)
Balance at December 31, 2024   5,427,795   $110,742,984   $7,698,304   $3,776,428   $(117,465,829)  $(609,420)  $479,316   $4,621,783 
Shares issued for overallotment   100,000    294,000    -    -    -    -    -    294,000 
Shares issued for overallotment   -    (28,030)   -    -    -    -    -    (28,030)
Shares issued for financing   11,887,895    56,907,745    -    -    -    -    -    56,907,745 
Share issue costs   -    (7,328,931)   2,225,727    -    -    -    -    (5,103,204)
Shares issued for the exercise of warrants   11,712,347    67,861,616    (2,716,408)   (4,753,719)   -    -    -    60,391,489 
Shares issued for the exercise of RSUs   216,738    1,249,123    (1,249,123)   -    -    -    -    - 
Warrants   -    -    -    1,103,825    -    -    -    1,103,825 
Share-based payments   -    -    1,388,957    -    -    -    -    1,388,957 
Net loss   -    -    -    -    (22,981,079)   -    -    (22,981,079)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    64,286    -    64,286 
Translation of foreign operations   -    -    -    -    -    -    (62,977)   (62,977)
Balance as of December 31, 2025   29,344,775   $229,698,507   $7,347,457   $126,534   $(140,446,908)  $(545,134)  $416,339   $96,596,795 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

6

 

 

Draganfly Inc.

Statement of Cash Flows

Expressed in Canadian Dollars

 

 

         
   For the years ended December 31, 
   2025   2024 
OPERATING ACTIVITIES          
Net loss for the year  $(22,981,079)  $(13,877,473)
Adjustments for:          
Amortization   9,028    11,285 
Depreciation   337,491    565,806 
Bad debt   90,252    186,627 
Change in fair value of derivative liability   2,648,288    (1,842,618)
Write down of inventory   259,091    627,106 
(Recovery) impairment of notes receivable   (69,646)   (40,020)
Finance and other costs   (869)   1,443,740 
(Gain) loss on sale of assets   16,564    11,432 
Share-based payments   1,388,956    1,182,618 
Adjustments for profit loss   (18,301,924)   (11,731,497)
Net changes in non-cash working capital items:          
Receivables   (402,244)   (266,418)
Inventory   (2,580,789)   (562,833)
Prepaids   (4,032,587)   617,702 
Trade payables and accrued liabilities   1,367,411    (231,812)
Customer deposits   (48,654)   361,580 
Deferred income   123,068    (20,993)
Cash used in operating activities   (23,875,719)   (11,834,271)
           
INVESTING ACTIVITIES          
Purchase of equipment   (923,037)   (167,257)
Disposal of equipment   -    103,923 
Repayment (Issuance) of notes receivable   69,646    40,020 
Cash used in investing activities   (853,391)   (23,314)
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   58,305,570    17,751,927 
Share issue costs   (5,131,132)   (2,656,180)
Proceeds from issuance of common shares for warrants exercised   56,038,319    373,415 
Repayment of loans   -    (85,058)
Repayment of lease liabilities   (154,146)   (357,778)
Cash provided by financing activities   109,058,611    15,026,326 
           
Effects of exchange rate changes on cash   (425,089)   (9,944)
Change in cash   84,329,501    3,168,741 
Cash and cash equivalents, beginning of year   6,252,409    3,093,612 
Cash and cash equivalents, end of year  $90,156,821   $6,252,409 
           
The following are included in cash flow from operating activities:          
Interest paid in cash  $37,480   $67,856 
Interest received   1,126,375    175,080 
Share issue costs in accounts payable   -    25,695 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

7

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the following stock exchanges: NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

Recognized as being at the forefront of UAV (“unmanned aerial vehicle”) technology for over two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, civil, military, agriculture, industrial inspections, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with IFRS® Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.

 

These consolidated financial statements were authorized for issue by the Board of Directors on March 24, 2026.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

 

Name of Subsidiary 

Place of Incorporation

   Ownership Interest 
Draganfly Innovations Inc. (“DII”)   Canada    100%
Draganfly Innovations USA, Inc. (“DI USA”)   US    100%
Dronelogics Systems Inc. (“Dronelogics”)   Canada    100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

Reclassification

 

Certain prior year amounts have been reclassified to conform to the fiscal 2025 presentation. Overall results were not impacted by the reclassification of items within the Operating Expenses of the Consolidated Statements of Comprehensive Loss. For the year ended December 31, 2025 the reclassified amounts were as follows:

 

 

             
   December 31, 2024 
   Before   Adjustment   After 
Professional fees  $3,016,594   $(1,581,182)  $1,435,412 
Office and miscellaneous  $1,853,578   $434,306   $2,287,884 
Employee and management expenses  $6,733,304   $1,146,876   $7,880,180 

 

8

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Foreign currency translation

 

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 

The functional currencies of the parent company and each subsidiary are as follows:

 

Draganfly Inc.   Canadian Dollar
Draganfly Innovations Inc.   Canadian Dollar
Draganfly Innovations USA, Inc.   US Dollar
Dronelogics Systems Inc.   Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

 

Equity transactions

 

The Company uses the residual value method with respect to the measurement of shares and warrants issued as private placement units for equity treatment warrants, whereby the carrying amount of the warrants is determined based on any difference between gross proceeds received and the estimated fair market value of the common shares. If the proceeds from the offering are less than or equal to the estimated fair market value of common shares issued, no value is assigned to the warrants. Warrants that are issued as payment to a finder or other transaction costs are accounted for as share-based payments.

 

Share-based payments

 

The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

 

The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

 

9

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.
b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.
c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

 

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 4,592,443 warrants, 23,858 options and 413,151 RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 

10

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Financial Instruments

 

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial assets/liabilities   Classification
Cash and cash equivalents   Fair value through profit or loss
Receivables   Amortized cost
Notes receivable   Fair value through profit or loss
Investments   Fair value through other comprehensive income
Trade payables   Amortized cost
Customer deposits   Amortized cost
Derivative liability   Fair value through profit or loss

 

a) Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument

basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

11

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Impairment of financial assets at amortized cost

 

The Company uses the “expected credit loss” model for calculating impairment and recognizes expected credit losses as a loss allowance for assets measured at amortized cost. The Company’s trade and other receivables are typically short-term with payments received within a twelve month period and do not have a significant financing component, therefore, the Company recognized an amount equal to the life time expected credit losses based on the Company’s historical experience. The carrying amount of these assets is net of any loss allowance. Specific reserves may be created for individual customers in exceptional circumstances. Bad debts are written off against the reserve.

 

Derecognition of financial assets

 

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

 

b) Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables and customer deposits are included in this category.

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 

Impairment of non-financial assets

 

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

  an intangible asset with an indefinite useful life; and
  an intangible asset not yet available for use;

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less

costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

12

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the

 

reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists

to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

 

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

13

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 to 60 days, which is consistent with market practice.

 

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

 

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 

Deferred Income

 

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

 

14

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Intangible Assets

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

 

Class of intangible asset   Useful live
Customer relationships   5 years
Software   5 years
Patents   5 years

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

 

Depreciation is generally calculated on a straight-line balance method with the exception of vehicles that are on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

 

Class of equipment   Depreciation rate
Computer equipment   3 years – straight line
Furniture and equipment   5 years – straight line
Leasehold improvements   Expected lease term
Vehicles   30% - declining balance

 

15

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

 

  (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale;
  (ii) its intention to complete the intangible asset and use or sell it;
  (iii) its ability to use or sell the intangible asset;
  (iv) how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
  (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
  (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

Newly adopted accounting standards

 

On January 1, 2024 the Company adopted amendments to IAS 1, Presentation of Financial Statements, issued by IASB. The amendment is to clarify the classification of a liability as either current or non-current based on the Company’s right at the end of the reporting period. There is no material impact on the disclosures or amounts reported in the consolidated financial statements.

 

16

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

New accounting standards issued not yet effective

 

In April 2024, the IASB issued IFRS 18, Presentation and Disclosures in Financial Statements, to replace IAS 1, Presentation of Financial Statements, effective January 1, 2027, with early adoption permitted. The new standard is aimed to set out overall requirements for presentation and disclosures in the financial statements. Management is reviewing the impact the standard will have on the consolidated financial statements.

 

In May 2024, the IASB issued amendments to IFRS 9, Financial Instruments, and IFRS 7, Financial Instruments: Disclosures to address the classification and measurement of financial instruments, with an emphasis to clarify the date of recognition and derecognition of financial asset and liabilities, effective January 1, 2026, with early adoption permitted. Management is reviewing the impact of these amendments, but they are not expected to have a material impact on the consolidated financial statements.

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS

 

Significant estimates and assumptions

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

 

 

17

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D)

 

Investments in Private companies

 

Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.

 

Expected credit losses on trade receivables and notes receivable

 

Amounts included in expected credit losses reflect the lifetime expected credit losses for trade receivables. Management determines allowances based on best estimates of future expected credit losses, considering historical credit loss experience, current economic conditions and forecasts of future economic conditions. Significant or unanticipated changes in economic conditions could impact the magnitude of future expected credit losses.

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company’s consolidated financial statements include:

 

  The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
  the classification of financial instruments;
  the assessment of revenue recognition using the five-step approach under IFRS 15; and
  the determination of the functional currency of each entity in the group.

 

18

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

4. RECEIVABLES

 

 

As at  December 31, 2025   December 31, 2024 
Trade accounts receivable  $947,939   $674,998 
Sales tax receivable   93,643    54,592 
Trade and other receivables, gross  $1,041,582   $729,590 
Current portion  $1,041,582   $573,390 
Long term portion   -    156,200 
Trade and other receivables  $1,041,582   $729,590 

 

The average trade credit allowed on the sale of goods is between 30 and 60 days from the date of shipment. Sales that require deposits are typically agreed to in advance to mitigate the potential for default.

 

The Company has recognized an allowance for doubtful trade receivables on accounts that are past due by more than 31 days based on best estimates of future expected credit losses and estimated irrecoverable amounts determined by reference to past experiences.

 

In determining the recoverability of a trade receivable, the Company considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the end of the reporting year. The concentration of credit risk is limited due to the fact that the customer base is diversified. The provision for expected credit losses is as follows:

 

Balance at December 31, 2023   (289,495)
Additional amounts provided for during the year   (140,011)
Balance at December 31, 2024   (429,506)
Additional amounts provided for during the year   (302,067)
Trade receivables written off during the year   186,211 
Foreign exchange   6,933 
Balance at December 31, 2025  $(538,429)

 

During the year ended December 31, 2025 the Company recorded an expected credit loss of $302,067 (2024 - $140,011).

 

The long-term receivable represents a refundable deposit that the Company has asked to have returned. The agreement allows for a two-year repayment term once the request has been made. Funds were requested in April of 2024. As this amount is due in less than 12 months it is now included with current receivables.

 

The Company assumes that the credit risk on a financial asset has increased if it is outstanding beyond the agreed payment terms. The Company considers a receivable to be default when the customer is unlikely to pay its obligations to the Company in full. The carrying amount of a receivable is written off (either partially or in full) to the extent that there is no realistic prospect of recovery.

 

Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

19

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

5. INVENTORY

 

 

   December 31, 2025   December 31, 2024 
Finished goods  $2,233,225   $954,453 
Work in process   107,287    16,409 
Raw materials   1,562,627    561,401 
Inventories  $3,903,139   $1,532,263 

 

During the year ended December 31, 2025, $5,454,204 (2024 - $4,529,655) of inventory was recognized in cost of sales including an allowance for obsolete and slow-moving inventory of $259,091 (2024 - $627,106).

 

Cost of sales consist of the following:

 

 

   December 31, 2025   December 31, 2024 
Inventory  $5,454,204   $4,529,655 
Consulting and services   603,324    451,984 
Other   352,299    181,212 
Cost of sales  $6,409,827   $5,162,851 

 

6. PREPAIDS AND DEPOSITS

 

 

   December 31, 2025   December 31, 2024 
Insurance  $526,555   $370,609 
Prepaid other   214,493    112,439 
Deposits   4,016,052    241,465 
Prepaid expenses and deposits  $4,757,100   $724,513 

 

Deposits consist of amounts required to be pre-paid in order for vendors to manufacture or supply goods.

 

20

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

7. EQUIPMENT

 

 

                     
   Computer Equipment   Furniture
and
Equipment
   Leasehold
Improvements
    Vehicles    Total 
Cost                         
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $60,343   $1,320,338 
Additions   6,876    137,562    2,359    -    146,797 
Disposals   (9,821)   (180,338)   -    -    (190,159)
Balance at December 31, 2024  $130,328   $997,416   $88,889   $60,343   $1,276,976 
Additions   62,145    908,221    1,300    -    971,666 
Disposals   (28,031)   (135,046)   (38,266)   -    (201,343)
Balance at December 31, 2025  $164,442   $1,770,591   $51,923   $60,343   $2,047,299 
                          
Accumulated depreciation                         
Balance at December 31, 2023  $58,178   $545,403   $6,790   $29,166   $639,537 
Charge for the year   37,881    143,885    17,845    9,354    208,965 
Disposals   (3,383)   (97,685)   -    -    (101,068)
Balance at December 31, 2024  $92,676   $591,603   $24,635   $38,520   $747,434 
Charge for the year   41,903    205,491    12,568    6,546    266,508 
Disposals   (24,246)   (121,765)   (12,706)   -    (158,717)
Balance at December 31, 2025  $110,333    675,329    24,497    45,066    855,225 
                          
Net book value:                         
December 31, 2024  $37,652   $405,813   $64,254   $21,823   $529,542 
December 31, 2025  $54,109   $1,095,262   $27,426   $15,277   $1,192,074 

 

Depreciation commences when assets are available for use. Depreciation expense for the year ended December 31, 2025 in the amount of $31,895 (2024 - $nil) is included in the cost of sales.

 

8. RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2023  $1,423,472 
Foreign exchange   31,567 
Balance at December 31, 2024 , 2025  $1,455,039 
      
Accumulated depreciation     
Balance at December 31, 2023  $701,785 
Charge for the year   356,841 
Foreign exchange   24,069 
Balance at December 31, 2024  $1,082,695 
Charge for the year   142,728 
Balance at December 31, 2025  $1,225,423 
      
Net book value:     
December 31, 2024  $372,344 
December 31, 2025  $229,616 

 

21

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

8. RIGHT OF USE ASSET (CONT’D)

 

Depreciation expense for the year ended December 31, 2025 in the amount of $7,771 (2024 - $nil) is included in the cost of sales.

 

The consolidated statement of financial position shows the following net book value amounts related to leases:

 

 

   December 31, 2025   December 31,  2024 
Buildings  $229,616   $372,344 

 

There were no additions to right of use assets for the years ended December 31, 2025 and 2024.

 

9. LEASE LIABILITES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities with terms ranging from five to seven years. The leases are calculated using incremental borrowing rates ranging from 7.45% to 11.7%.

 

 

   Total 
Balance at December 31, 2023  $790,023 
Interest expense   65,378 
Lease payments   (423,157)
Foreign exchange   (4,223)
Balance at December 31, 2024  $428,021 
Interest expense   36,711 
Lease payments   (190,857)
Balance at December 31, 2025  $273,875 

 

Which consists of:

 

   December 31, 2025   December 31, 2024 
Current lease liability  $143,624   $154,147 
Non-current lease liability   130,251    273,874 
Ending balance  $273,875   $428,021 

 

Maturity analysis  December 31, 2025   December 31, 2024 
Less than one year  $165,022   $190,856 
One to three years   141,519    282,419 
Four to five years   -    71,836 
Total undiscounted lease liabilities   306,541    545,111 
Amount representing interest   (32,666)   (117,090)
Lease liability  $273,875   $428,021 

 

Variable lease payments of $149,843 (2024 - $77,626) have been recognized in profit and loss.

 

22

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

10. TRADE PAYABLES AND ACCRUED LIABILITIES

 

 

   December 31, 2025   December 31, 2024 
Trade accounts payable  $667,396   $609,869 
Accrued liabilities   2,729,947    1,789,318 
Trade payables and accrued liabilities  $3,397,343   $2,399,187 

 

11. DEFERRED REVENUE

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as the services are rendered.

 

 

   December 31, 2025   December 31, 2024 
Deferred, revenue beginning  $86,681   $107,674 
Revenue recognized   (90,781)   (21,852)
Unearned revenues received   223,426    1,744 
Foreign exchange   (9,577)   (885)
Deferred income gross  $209,749   $86,681 
Current portion  $165,237   $18,542 
Long term portion   44,512    68,139 
Deferred Income net  $209,749   $86,681 

 

Deferred revenue of $165,237 as of December 31, 2025 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangement and will be recognized according to the terms of that arrangement over the next 2.5 years.

 

12. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2025,

 

  The Company issued 216,738 common shares for the vesting of restricted share units.
  On May 5, 2025, the Company issued 1,715,000 units consisting of one common share and one warrant and in a financing for $4,973,404 with share issue costs of $829,316, including $163,757 related to broker warrants, for net proceeds of $4,144,088. The value of the issuance was allocated $4,545,997 to the shares and $427,407 to the warrants based on the residual method. This issuance included an overallotment of 100,000 warrants convertible to 100,000 shares.
  The Company issued 100,000 shares related to the overallotment of the May 5, 2025 share issuance for gross proceeds of $294,000 with share issue costs of $28,030 for net proceeds of $265,970.
  On June 12, 2025 the Company issued 5,500,000 units consisting of one common share and one warrant in a financing for $18,758,889 with share issue costs of $2,258,143, including $632,798 related to broker warrants, for net proceeds of $16,500,747. The value of the issuance was allocated $18,082,472 to the shares and $676,418 to the warrants based on the residual method.
  On July 21, 2025 the Company issued 4,672,895 units consisting of one common share and one warrant in a financing for $34,279,276 with share issue costs of $4,100,807, including $1,429,172 related to broker warrants, for net proceeds of $30,178,469. The warrants were valued at $nil based on the residual method.
  11,712,347 shares were issued for the exercise of warrants
  The Company incurred share issue costs of $140,000 related to the June 30, 2023 base shelf prospectus and included in share issuance costs.

 

23

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

12. SHARE CAPITAL (CONT’D)

 

During the year ended December 31, 2024,

 

  The Company issued 25,353 common shares for the vesting of restricted share units.
  The Company issued 1,991,668 common shares for the exercise of warrants
  On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498, including $72,186 related to broker warrants, for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025.36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. The shares had a carrying value of $nil on cancellation.
  On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615, including $154,860 related to broker warrants, for net proceeds of $4,102,553. Of the total share issuance costs $624,755 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.
  On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676, including $100,651 related to broker warrants, for net proceeds of $2,376,374. The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.
  On November 19, 2024 the Company issued 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant in a financing for $5,272,234 with share issue costs of $755,397, including $181,758 related to broker warrants, for net proceeds of $4,516,837. The value of the issuance was allocated $329,515 to the shares and $4,942,719 to the warrants including $1,977,088 allocated to the prefunded warrants based on the residual method.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

24

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

12. SHARE CAPITAL (CONT’D)

 

As at December 31, 2025, the Company had the following options outstanding and exercisable:

 

 

Grant Date  Expiry Date  Exercise Price  

Remaining

Contractual Life

(years)

  

Number of

Options

Outstanding

  

Number of

Options

Exercisable

 
October 30, 2019  October 30, 2029  $62.50    4.33    10,464    10,464 
April 30, 2020  April 30, 2030  $62.50    4.82    240    240 
April 30, 2020  April 30, 2030  $96.25    4.82    4,400    4,400 
November 24, 2020  November 24, 2030  $62.50    5.39    1,280    1,280 
February 2, 2021  February 2, 2031  $330.00    5.58    1,200    1,200 
March 8, 2021  March 8, 2026  $347.50    0.69    400    400 
April 27, 2021  April 27, 2031  $253.75    5.81    3,640    3,640 
September 9, 2021  September 9, 2026  $121.00    1.19    1,034    1,034 
November 9, 2023  November 9, 2033  $15.75    8.34    1,200    1,200 
                 23,858    23,858 

 

   Number of Options  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2023   35,954   $112.00 
Forfeited   (4,350)   106.83 
Outstanding, December 31, 2024   31,604   $112.05 
Forfeited   (3,746)   113.55 
Expired   (4,000)   80.00 
Outstanding, December 31, 2025   23,858   $116.34 

 

No options were granted by the Company for the years ended December 31, 2025 and 2024.

 

During the year ended December 31, 2025, the Company recorded $3,447 (2024- $60,803) in stock-based compensation in relation to the vesting of stock options.

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company in its discretion and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). RSUs can have 18-month to a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

25

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

12. SHARE CAPITAL (CONT’D)

 

As at December 31, 2025, the Company had the following RSUs outstanding:

 

   Number of RSU’s 
Outstanding, December 31, 2023   44,545 
Vested   (25,353)
Issued   185,240 
Forfeited   (16,332)
Outstanding, December 31, 2024   188,100 
Vested   (216,738)
Issued   450,964 
Forfeited   (9,175)
Outstanding, December 31, 2025   413,151 

 

Each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months to 3 years from the grant date. In addition, 9,175 RSU’s were forfeited by employees who have left the Company.

 

During the year ended December 31, 2025, the Company recorded share-based payment expense of $1,385,510 (2024: $1,121,815) for RSU’s, based on the fair values of RSU’s granted which are calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the year ended December 31, 2024 the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company’s functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD so are also accounted for as a liability. In addition, the Company also issued pre-funded warrants with an exercise price in Canadian dollars (“Pre-funded Warrants”). These are also treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also accounted for as a liability as these also contain clauses that do not meet the fixed for fixed test.

 

On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to CAD $0.2250 or CAD $5.625 on a post share consolidation basis. The exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of CAD $5.6925. For the October 2023 issuance and the April 2024 issuance, the warrant agreements were further amended as of August 7, 2024 to remove the cashless exercise feature and any anti-dilution clauses that would lead to variability in settlement so they now meet the requirement for equity classification. The warrants were fair valued on August 7, 2024 and transferred to equity.

 

On November 19, 2024 the exercise prices of the April 2024 warrants, August 2024 warrants and the October 2023 warrants were amended to CAD$3.3086 from CAD$5.625 and CAD$5.6925 respectively.

 

26

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

12. SHARE CAPITAL (CONT’D)

 

The warrants issued as part of the August 2024 issuance and the November 2024 issuance were issued with a CAD exercise price, no cashless exercise feature and no anti-dilution clauses that would lead to variability in settlement.

 

To determine the a fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

 

2025 issuances  May Issuance   June Issuance   July Issuance 
   Broker   Broker   Broker 
Volatility   122.15%   125.42%   131.17%
Risk free rate   3.63%   3.85%   3.89%
Expected life   3 years    3 years    3 years 
Expected dividend yield   0%   0%   0%

 

2024 issuances  February Issuance   April Issuance   August Issuance   November Issuance 
   Warrants   Broker   Warrants   Broker   Broker   Broker 
Volatility   119.23%   107.8%   119.80%   108.67%   118.87%   115.27%
Risk free rate   4.33%   4.48%   4.65%   4.62%   3.74%   4.24%
Expected life   5 years    3 years    5 years    3 years    3 years    3 years 
Expected dividend yield   0%   0%   0%   0%   0%   0%

 

Warrant Derivative Liability

 

Balance at December 31, 2023  $4,196,125 
Warrants issued   7,282,325 
Exercised   (3,661,283)
Change in fair value of warrants outstanding   (1,842,618)
Reclassified to equity   (3,776,428)
Balance at December 31, 2024  $2,198,121 
Exercised   (4,353,939)
Change in fair value of warrants outstanding   2,648,288 
Balance at December 31, 2025  $492,470 

 

Details of liability warrants and their fair values are as follows:

 

 

Issue Date 

Exercise

Price

  

Number of

Warrants

Outstanding at

December

31, 2025

  

Fair Value

at December

31, 2025

  

Number of

Warrants

Outstanding

at December

31, 2024

  

Fair Value

at December

31, 2024

 
Derivative Liability                    
February 26, 2024 (1)  US$ 4.4025     61,911   $492,470    474,332   $2,198,121 
         61,911   $492,470    474,332   $2,198,121 

 

  1) The warrants expire February 26, 2029.

 

27

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

12. SHARE CAPITAL (CONT’D)

 

The fair values of the derivative warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

 SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS 

   December 31, 2025   December 31, 2024 
Risk free interest rate   3.55%   4.38%
Expected volatility   139.39%   124.06%
Expected life   3.16 years    4.16 years 
Expected dividend yield   0%   0%

 

As at December 31, 2025, the Company had the following warrants outstanding:

 

 

Date issued  Expiry date  Exercise price  

Number of warrants

outstanding

December 31, 2025

 
October 30, 2023  October 30, 2026  CAD$23.20    12,800 
February 26, 2024  February 26, 2029  US$4.4025    61,911 
May 5, 2025  May 5, 2030  CAD$3.9779    7,500 
June 12, 2025  June 12, 2030  CAD$5.0768    1,014,500 
July 21, 2025  July 21, 2030  CAD$7.3579    3,495,732 
            4,592,443 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2025, was 4.5 years (December 31, 2024 – 4.5 years).

  

  

Number of Warrants

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2023   342,992   $15.75 
Exercised   (1,991,668)   0.96 
Issued   5,376,370    3.35 
Expired   (10,192)   125.00 
Outstanding, December 31, 2024   3,717,502   $5.16 
Issued   12,587,289    5.81 
Exercised(1)   (11,712,348)   4.80 
Outstanding December 31, 2025   4,592,443   $6.90 

 

1)The weighted average share price at the time of the 766,556 broker warrants exercised was $7.99 USD($11.05 CAD).

 

28

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

13. SEGMENTED INFORMATION

 

As at and for the year ended December 31, 2025 the Company operates in 2 reportable segments (as at and for the year ended December 21, 2024 – 2). The Company organizes its two segments based on its product line as well as a corporate segment. The two segments are Drones and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV) while the Corporate segment includes all costs not directly associated with the Drone segment. The Company aggregates the information for the segments by analyzing the revenue stream and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.). The Vital segment derived its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance and will no longer be an operating segment going forward. The Vital product was developed to address COVID-19 during the pandemic which has since waned and as a result, is no longer a core focus of the Company.

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, chief operating officer and chief financial officer.

 

December 31, 2025  Drones   Corporate   Total 
Sales of goods  $6,869,815   $-   $6,869,815 
Provision of services   861,348    -    861,348 
Total revenue  $7,731,163   $-   $7,731,163 
Segment loss  $9,116,654   $14,748,492   $23,865,146 
Finance and other costs   1,081,863    7,102    1,088,965 
Depreciation   329,144    8,347    337,491 
Amortization   9,028    -    9,028 
Change in fair value of derivative liability   -    (2,648,288)   (2,648,288)
Loss (recovery) on write-off of notes receivable   -    69,646    69,646 
Loss on write down of inventory   259,091    -    259,091 
Net loss for the year  $10,795,780   $12,185,299   $22,981,079 

 

December 31, 2024  Drones   Corporate   Total 
Sales of goods  $5,368,476   $-   $5,368,476 
Provision of services   1,192,579    -    1,192,579 
Total revenue  $6,561,055   $-   $6,561,055 
Segment loss  $5,954,785   $4,728,628   $10,683,413 
Finance and other costs   107,225    -    107,225 
Depreciation   551,117    14,689    565,806 
Amortization   11,285    -    11,285 
Change in fair value of derivative liability   -    1,842,618    1,842,618 
Loss on write-off of notes receivable   -    40,020    40,020 
Loss on write down of inventory   627,106    -    627,106 
Net loss for the year  $7,251,518   $6,625,955   $13,877,473 

 

29

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars 

 

 

13. SEGMENTED INFORMATION (CONT’D)

 

   2025   2024 
Geographic segmentation is as follows:  For the years ended December 31, 
   2025   2024 
Non-current assets          
Canada  $980,758   $1,117,513 
United States   548,473    - 
   $1,529,231   $1,117,513 
Revenue          
Canada  $7,709,945   $6,523,341 
United States   21,218    37,714 
Revenue  $7,731,163   $6,561,055 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

14. OFFICE AND MISCELLANEOUS

 

   2025   2024 
  

For the years ended December 31,

 
   2025   2024 
Advertising, Marketing, and Investor Relations  $2,525,878   $848,821 
Compliance fees   525,074    289,238 
Business development   1,003,381    257,273 
General freight   473,497    

139,627

 
Subscription, Membership & IT Support   525,803    298,140 
General office   829,900    454,785 
Office and Miscellaneous Expenses  $5,883,533   $2,287,884 

 

 

15. OTHER EXPENSE

  

   2025   2024 
   For the years ended December 31, 
   2025   2024 
Share issue costs  $-   $1,254,629 
Write off of accounts receivable   297,746    140,011 
Other   (1,641)   13,169 
Total Other expenses  $296,105   $1,407,809 

 

 

16. RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group

(“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2025, the Company incurred fees of $411,714 (December 31, 2024 - $273,475) . As at December 31, 2025, the Company was indebted to this company in the amount of $nil (December 31, 2024 - $nil).

 

30

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

16. RELATED PARTY TRANSACTIONS (CONT’D)

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2025, the Company incurred fees of $629,526 (December 31, 2024 - $487,688) . As at December 31, 2025, the Company was indebted to this company in the amount of $nil (December 31, 2024 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2025, the Company incurred fees of $123,378 (December 31, 2024 - $116,266. As at December 31, 2025, the Company was indebted to Scott Larson in the amount of $9,363 (December 31, 2024 - $23,931).

 

For the year ended December 31, 2025 and 2024 salary and commissions were paid to family members of key management. In addition, during 2025, one family member was paid as a contractor prior to becoming an employee. The amounts paid were $338,649 for the year ended December 31, 2025 and $184,964 for the year ended December 31, 2024

 

Trade receivables/payables and accrued receivables/payables:

 

As at December 31, 2025, the Company had $147,782 (December 31, 2024 - $208,963) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2025 and 2024 included:

 

   2025   2024 
   For the years ended December 31, 
   2025   2024 
Director fees  $519,950   $504,619 
Salaries   1,334,584    998,951 
Share-based payments   889,386    768,228 
Total  $2,743,920   $2,271,798 

 

Other related party transactions

 

   2025   2024 
   For the years ended December 31, 
   2025   2024 
Management fees paid to a company controlled by CEO and director  $629,526   $487,688 
Management fees paid to a company that the CEO holds an economic interest in   411,714    273,475 
Salary and commission paid to family of key management   294,321    184,964 
Contractor fees paid to family of key management   44,327    - 
Management fees paid to a company controlled by a director   123,378    116,266 
Management fees paid to a company, total   $1,503,266   $1,062,393 

 

31

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers to reduce the credit risk of receivable balances.

 

Receivables

 

Receivables primarily consist of trade receivables, accrued receivables and taxes receivable. The Corporation’s exposure to credit risk is associated with trade receivables and the potential risk that any customer is unable to pay amounts due. Allowances for doubtful accounts and bad debts are estimated as at the balance sheet date. The amounts reported for trade receivables on the balance sheet are net of allowances for doubtful accounts and the net carrying value represents the Corporation’s maximum exposure to credit risk.

 

Management reviews past due trade receivables balances on a continuous basis to monitor potential credit risks. Accounts are considered for impairment on a case-by-case basis when they are past due or when objective evidence is received that a customer may default. A number of factors are considered in determining the likelihood of impairment. All bad debt write-offs and changes in the doubtful trade receivables reserve are expensed or credited, as applicable, to selling expenses in the consolidated statement of comprehensive loss.

 

Draganfly believes that credit risk associated with its trade receivables is limited for the following reasons:

 

  Trade receivables balances are spread amongst a broad customer base;
  The aging profile of trade receivables balances is systematically monitored by management; and
  Payments for larger orders are requested at least partially in advance of products being shipped

 

The Company’s aging of receivables was as follows:

 

   December 31, 2025   December 31, 2024 
0 – 30 days  $264,885   $346,979 
31 – 60 days   271,836    150,575 
61 – 90 days   100,659    32,002 
91 + days   404,202    200,034 
Total receivables  $1,041,582   $729,590 

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

32

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2025:

 

   1 year   1 – 5 years   Total 
Trade payable and accrued liabilities  $3,397,343   $-   $3,397,343 
Customer deposits   417,641    -    417,641 
Deferred income   165,237    44,512    209,749 
Derivative liability   492,470    -    492,470 
Lease liability   143,624    130,251    273,875 
Financial liabilities  $4,616,315   $174,763   $4,791,078 

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

   December 31, 2025   December 31, 2024 
   USD  

Change in

currency

  

Effect on

after tax

loss

   USD  

Change in

currency

  

Effect on

after tax

loss

 
Net monetary assets  $61,368,507    10%  $8,411,168   $4,024,827    10%  $551,643 
Net monetary liabilities   (273,323)   10%   (37,462)   (236,518)       10%   (32,417)

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

 

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

 

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

33

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Cash, equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the consolidated statements of financial position. These financial assets are measured at fair value through profit and loss.

 

December 31, 2025  Level 1   Level 2   Level 3   Total 

Cash

 

$

90,156,821  

$

-  

$

-  

$

90,156,821 
Equity securities in investee companies  71,429   -   -   71,429 
Derivative liability   -    -    (492,470)   (492,470)
Total  $90,228,250   $-   $(492,470)  $89,735,780

 

December 31, 2024  Level 1   Level 2   Level 3   Total 

Cash

   -    -    -    - 
Equity securities in investee companies  $14,286   $-   $-   $14,286 
Derivative liability   -    -    (2,198,121)   (2,198,121)
Total  $14,286   $-   $(2,198,121)  $(2,183,835)

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

Type   Valuation technique   Key inputs   Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

● Share price

● Risk free interest rate

● Dividend yield

 

Key unobservable inputs

● Expected volatility

 

The estimated fair value would increase (decrease) if:

● The price was higher (lower)

● The risk-free rate was higher (lower)

● The dividend yield was lower (higher)

● The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
      

Year ended

December 31, 2025

  

Year ended

December 31, 2024

 
Volatility   20%  $25,437   $201,109 

 

Capital Management

 

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity.

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed

capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2024.

 

34

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2025

Expressed in Canadian Dollars

 

 

18. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the consolidated statements of comprehensive loss for the years ended December 31, 2025 and 2024:

 

   December 31, 2025   December 31, 2024 
Loss before income taxes  $22,981,079   $13,877,473 
Canadian statutory rates   27%   27%
Expected income tax recovery   6,204,900    3,725,300 
Impact of different foreign statutory tax rates   (28,500)   - 
Non-deductible items   (1,300,900)   (99,400)
Share issue costs   779,600    779,600 
Adjustments to prior years provision versus statutory tax returns   650,500    258,200 
Change in deferred tax asset not recognized   (6,305,600)   (4,663,700)
Income tax  $-   $- 

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

   December 31, 2025   December 31, 2024 
Deferred income tax assets (liabilities):          
Share issuance costs  $3,088,000   $1,736,000 
Non-capital losses   29,153,000    24,055,000 
Property and equipment   493,000    457,000 
Scientific Research and Experimental Development   377,000    377,000 
Total deferred income tax assets  $33,111,000   $26,625,000 
Deferred income tax not recognized   (33,111,000)   (26,625,000)
Net deferred tax assets  $-   $- 

 

The Company has non-capital loss carry forward of approximately $97,619,071 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2029 to 2045. The Company has non-capital loss carry forward of $10,981,880 CAD ($8,056,735 USD) which may be carried forward to apply against future year income tax for tax purposes in the United States, subject to the final determination by the tax authorities, expiring in the years 2040 to 2045.

 

19. SUBSEQUENT EVENTS

 

On February 6, 2026 1,196 warrants were exercised from the February 2024 issuance for proceeds of $5,265 USD ($7,168 CAD).

 

On February 23, 2026, the Company announced that it completed an underwritten share placement of 5,030,000 common shares and 2,120,000 pre-funded warrants. Each unit was sold at a price of $7.00 USD for gross proceeds of $50 million ($68.4 million CAD). Net proceeds of $31.8 million USD ($43.5 million CAD) was received after share issue costs of $3,403,311 USD ($4,658,792 CAD). The pre-funded warrants have an exercise price of $0.00014 CAD and may be exercised at any time until they are exercised in full. As part of this transaction 357,500 warrants were issued to the underwriter with an exercise price of $11.98744 CAD ($8.75 USD) and will have a term of 3 years.

 

On March 3, 2026 1,413,531 of the pre-funded warrants from the February 2026 issuance were exercised using the cashless exercise option. The resulting number of shares issued was 1,413,511.

 

On March 6, 2026 689,865 of the pre-funded warrants from the February 2026 issuance were exercised using the cashless exercise option. The resulting number of shares issued was 689,854.

 

On March 10, 2026 16,604 of the pre-funded warrants from the February 2026 issuance were exercised using the cashless exercise option. The resulting number of shares issued was 16,603.

 

35